Epidemiology and in vitro activity of ceftazidime-avibactam and comparator agents against multidrug-resistant isolates of Enterobacterales and Pseudomonas aeruginosa collected in Latin America as part of the ATLAS surveillance program in 2015¿2020 Mark G. Wise; James A. Karlowsky; Elkin V. Lemos-Luengas; Rafael R. Valdez; Daniel F. Sahm;

In vitro activity of imipenem/relebactam against non-Morganellaceae Enterobacterales and Pseudomonas aeruginosa in Latin America: SMART 2018¿2020 James A. Karlowsky; Sibylle H. Lob; Fakhar Siddiqui; Jacqueline Pavia; C. Andrew DeRyke; Katherine Young; Mary R. Motyl; Daniel F. Sahm;

Travestis, transgender women and young MSM are at high risk for PrEP early loss to follow-up in Rio de Janeiro, Brazil Amanda Echeverría-Guevara; Lara E. Coelho; Valdiléa G. Veloso; Maria C. Pimenta; Brenda Hoagland; Ronaldo I. Moreira; Iuri Leite; Emília M. Jalil; Sandra W. Cardoso; Thiago S. Torres; Beatriz Grinsztejn;